News

The agreement provides Scripta patients with another option when purchasing medication.

CDMO’s Taoyuan City plant is set to provide customers with products ranging from emulsions to gels.

As a result, the parties will work together to advise pharma clients on subject matters pertaining to strategy and planning, market access, policy analysis, and more. .

The experienced manager will head the company’s US plant.

Total deal expected to be worth approximately $7.3 billion.

The executive joins the logistics provider with over two decades of relevant experience.

AI, ML-based deal builds on the parties’ existing relationship.

Parties are expected to be fully integrated by the second half of 2024.

Product is expected to maintain a steady temperature setting between 65°F (18°C) and 80°F (27°C).

The pharma and biotech exec will begin his role on Aug. 1.

One billion DSCSA transaction histories were reportedly processed on the company network.

William Fletcher brings his serialization and traceability knowledge to the healthcare solutions company.

CDMO’s Turku addition will span over 69,000 square feet and support the production of ATMPs.

Pandemic preparedness and curbing PBMs among the pending legislation that will have to wait until after summer recess.

Drug safety database can now be used by life sciences organizations that are looking to develop, manufacture, and market regulated products in the country.

The logistics provider is now a member of an industry group of experts in Italy.

Purchase helps expands business’ label and packing services.

Product reportedly offers enhanced pharma supply chain visibility and risk analysis.

Updated deal will cover exclusive US commercialization for several of Alvotech’s biosimilars.

Collaboration aims to help pharmaceuticals drive efficiencies and business value.

With FDA’s compliance deadline only three months away, the tech-supply chain partnership is expected to help manufacturers and wholesalers meet the Nov. 27 deadline.

Sterile injectable plant—struck by tornado—is currently being assessed.

With goal of improving patients’ overall care, Pittsburgh-based pharmacy is aiming to be licensed in all 50 states.

Solution includes assistance with submitting regulatory submissions.

The agency proposes significant revisions to oversight programs for drugs and medical products.

Company anticipates launch of a standalone organization.

The 19,500 square-foot warehouse will support API manufacturing activities, all the way through commercialization.

Experienced exec joins the agency with over three decades of driving brand growth.